πŸ‡ΊπŸ‡Έ FDA
Patent

US 9868777

CMV neutralizing antigen binding proteins

granted A61PA61P31/12

Quick answer

US patent 9868777 (CMV neutralizing antigen binding proteins) held by The Board of Regents of the University of Texas System expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61P, A61P31/12